Stoke Therapeutics Inc (NASDAQ:STOK)
| 3.94 Delayed Data As of Dec 01 |  +0.15 / +3.96%Today’s Change | 3.35 Today|||52-Week Range 14.00 | -57.31% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2017 | 2018 | -- | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | -- | -- | -- |
| Depreciation And Amortization | 113.0K | 214.0K | -- | -- | ||
| Operating Expenses | Gross Income | -113.0K | -214.0K | -- | -- | |
| General Expenses | 5.4M | 12.6M | -- | -- | ||
| Research And Development | 3.5M | 8.2M | -- | -- | ||
| Total Operating Expenses | 5.5M | 12.8M | -- | -- | ||
| Non-Operating Expenses | Operating Income | -5.5M | -12.8M | -- | -- | |
| Interest Expense On Debt | 21.0K | 0.00 | -- | -- | ||
| Other Expenses | -4.0K | -10.0K | -- | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -5.6M | -12.5M | -- | -- | |
| Net Income | -5.6M | -12.5M | -- | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 31.3M | 31.3M | -- | -- | |
| Shares To Calculate EPS Diluted | 31.3M | 31.3M | -- | -- | ||
| Earnings Per Share | EPS | -$0.18 | -$0.40 | -- | -- | |
| EPS Diluted | -$0.18 | -$0.40 | -- | -- | ||
